ArticleHeart rhythm O22026
First catheter ablation in Fiji: Innovative use of a pacemaker programmer as a recording system.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wolff-Parkinson-White syndrome is a potentially life-threatening condition for which catheter ablation is considered first-line therapy, yet electrophysiology (EP) services remain unavailable in many low- and middle-income countries. We describe the innovative use of a pacemaker programmer as an EP recording system for the first catheter ablation procedures performed in Fiji. 2 patients with symptomatic Wolff-Parkinson-White underwent ablation using a repurposed pacemaker programmer for intracardiac signal recording in combination with an IBI-1500T9 radiofrequency generator for energy delivery. Both procedures were successful, achieving elimination of accessory pathway conduction and complete resolution of symptoms without complications. These cases demonstrate that repurposing readily available cardiac device equipment can enable lifesaving EP procedures in resource-limited settings and establish a foundation for future service development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.